NM_000431.4:c.769-38C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000431.4(MVK):​c.769-38C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.171 in 1,595,588 control chromosomes in the GnomAD database, including 23,953 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2123 hom., cov: 33)
Exomes 𝑓: 0.17 ( 21830 hom. )

Consequence

MVK
NM_000431.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.464

Publications

13 publications found
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-109591203-C-T is Benign according to our data. Variant chr12-109591203-C-T is described in ClinVar as Benign. ClinVar VariationId is 439922.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MVKNM_000431.4 linkc.769-38C>T intron_variant Intron 8 of 10 ENST00000228510.8 NP_000422.1 Q03426B2RDU6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MVKENST00000228510.8 linkc.769-38C>T intron_variant Intron 8 of 10 1 NM_000431.4 ENSP00000228510.3 Q03426

Frequencies

GnomAD3 genomes
AF:
0.164
AC:
24946
AN:
152136
Hom.:
2127
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.169
Gnomad AMI
AF:
0.216
Gnomad AMR
AF:
0.154
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.0987
Gnomad MID
AF:
0.182
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.159
AC:
39983
AN:
250774
AF XY:
0.160
show subpopulations
Gnomad AFR exome
AF:
0.169
Gnomad AMR exome
AF:
0.145
Gnomad ASJ exome
AF:
0.184
Gnomad EAS exome
AF:
0.150
Gnomad FIN exome
AF:
0.104
Gnomad NFE exome
AF:
0.177
Gnomad OTH exome
AF:
0.166
GnomAD4 exome
AF:
0.172
AC:
248041
AN:
1443334
Hom.:
21830
Cov.:
29
AF XY:
0.170
AC XY:
122485
AN XY:
719038
show subpopulations
African (AFR)
AF:
0.164
AC:
5412
AN:
33042
American (AMR)
AF:
0.145
AC:
6466
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
4954
AN:
26050
East Asian (EAS)
AF:
0.160
AC:
6337
AN:
39602
South Asian (SAS)
AF:
0.138
AC:
11879
AN:
85878
European-Finnish (FIN)
AF:
0.107
AC:
5702
AN:
53126
Middle Eastern (MID)
AF:
0.203
AC:
1122
AN:
5540
European-Non Finnish (NFE)
AF:
0.179
AC:
195927
AN:
1095668
Other (OTH)
AF:
0.171
AC:
10242
AN:
59730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
11745
23489
35234
46978
58723
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6864
13728
20592
27456
34320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.164
AC:
24954
AN:
152254
Hom.:
2123
Cov.:
33
AF XY:
0.158
AC XY:
11788
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.168
AC:
6991
AN:
41544
American (AMR)
AF:
0.154
AC:
2353
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
665
AN:
3472
East Asian (EAS)
AF:
0.141
AC:
729
AN:
5174
South Asian (SAS)
AF:
0.130
AC:
626
AN:
4828
European-Finnish (FIN)
AF:
0.0987
AC:
1049
AN:
10626
Middle Eastern (MID)
AF:
0.178
AC:
52
AN:
292
European-Non Finnish (NFE)
AF:
0.175
AC:
11924
AN:
67998
Other (OTH)
AF:
0.174
AC:
368
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1084
2168
3251
4335
5419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
445
Bravo
AF:
0.170
Asia WGS
AF:
0.150
AC:
520
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22246419, 27884173, 27190114) -

Sep 13, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 28% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. -

Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.4
DANN
Benign
0.74
PhyloP100
0.46
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35191208; hg19: chr12-110029008; COSMIC: COSV57331954; COSMIC: COSV57331954; API